Graham Capital Management »

Bridgebio Pharma shares owned by Graham Capital Management

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $89M 73M 1.21
2023-09-30 $54M 56M 0.96

More positions owned by Graham Capital Management

Ishares Tr Russell 2000 Etf (IWM)
Microstrategy Cl A New Put Option (MSTR)
Zillow Group Note 0.750% 9/0 (Principal)
Microstrategy Note 0.750%12/1 (Principal)
Permian Resources Corp Note 3.250% 4/0 (Principal)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Tilray Brands Note 5.200% 6/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Transocean Deb 4.000%12/1 (Principal)
Bill Holdings Note 12/0 (Principal)
Opko Health Note 4.500% 2/1 (Principal)
Bloom Energy Corp Note 2.500% 8/1 (Principal)
Maxeon Solar Technologies Lt SHS Call Option (MAXN)
Maxeon Solar Technologies Lt Note 6.500% 7/1 (Principal)
Zscaler Note 0.125% 7/0 (Principal)

View all positions for Graham Capital Management

Top funds holding Bridgebio Pharma

Braidwell
Graham Capital Management
Aristeia Capital
D. E. Shaw & Co
Point72 Asset Management
Wells Fargo & Company
Lazard Asset Management
683 Capital Management
MacKay Shields
Wolverine Asset Management
Lord, Abbett & Co
Calamos Advisors
Weiss Asset Management LP[1
Ubs Global Asset Management Americas
SSI Investment Management

View all funds holding Bridgebio Pharma